{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T04:04:40Z","timestamp":1780373080871,"version":"3.54.1"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T00:00:00Z","timestamp":1703548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["2RO1 CA177875"],"award-info":[{"award-number":["2RO1 CA177875"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["RO1 CA2558451"],"award-info":[{"award-number":["RO1 CA2558451"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5P30CA044579"],"award-info":[{"award-number":["5P30CA044579"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["5F30CA268842-02"],"award-info":[{"award-number":["5F30CA268842-02"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA009109"],"award-info":[{"award-number":["T32 CA009109"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["T32 CA009109"],"award-info":[{"award-number":["T32 CA009109"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100005190","name":"Melanoma Research Alliance","doi-asserted-by":"publisher","award":["ID612638"],"award-info":[{"award-number":["ID612638"]}],"id":[{"id":"10.13039\/100005190","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["T32 GM007267"],"award-info":[{"award-number":["T32 GM007267"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2024,3,9]]},"DOI":"10.1038\/s41416-023-02530-5","type":"journal-article","created":{"date-parts":[[2023,12,26]],"date-time":"2023-12-26T08:02:11Z","timestamp":1703577731000},"page":"555-567","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["PTEN-restoration abrogates brain colonisation and perivascular niche invasion by melanoma cells"],"prefix":"10.1038","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2934-1410","authenticated-orcid":false,"given":"Sarah","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline P.","family":"Riedstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetha","family":"Anandh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2663-1949","authenticated-orcid":false,"given":"Andrew C.","family":"Dudley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,26]]},"reference":[{"key":"2530_CR1","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.3390\/cancers12061640","volume":"12","author":"P Becco","year":"2020","unstructured":"Becco P, Gallo S, Poletto S, Frascione MPM, Crotto L, Zaccagna A, et al. Melanoma brain metastases in the era of target therapies: an overview. Cancers (Basel). 2020;12:1640.","journal-title":"Cancers (Basel)"},{"key":"2530_CR2","doi-asserted-by":"publisher","first-page":"102083","DOI":"10.1016\/j.ctrv.2020.102083","volume":"89","author":"R Gutzmer","year":"2020","unstructured":"Gutzmer R, Vordermark D, Hassel JC, Krex D, Wendl C, Schadendorf D, et al. Melanoma brain metastases \u2013 interdisciplinary management recommendations 2020. Cancer Treat Rev. 2020;89:102083.","journal-title":"Cancer Treat Rev"},{"key":"2530_CR3","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11940-017-0449-2","volume":"19","author":"AS Berghoff","year":"2017","unstructured":"Berghoff AS, Preusser M. Targeted therapies for melanoma brain metastases. Curr Treat Options Neurol. 2017;19:13.","journal-title":"Curr Treat Options Neurol"},{"key":"2530_CR4","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S1470-2045(17)30429-1","volume":"18","author":"MA Davies","year":"2017","unstructured":"Davies MA, Saiag P, Robert C, Grob JJ, Flaherty KT, Arance A, et al. Dabrafenib plus trametinib in patients with BRAF(V600)-mutant melanoma brain metastases (COMBI-MB): a multicentre, multicohort, open-label, phase 2 trial. Lancet Oncol. 2017;18:863\u201373.","journal-title":"Lancet Oncol"},{"key":"2530_CR5","doi-asserted-by":"publisher","first-page":"1692","DOI":"10.1016\/S1470-2045(21)00545-3","volume":"22","author":"HA Tawbi","year":"2021","unstructured":"Tawbi HA, Forsyth PA, Hodi FS, Algazi AP, Hamid O, Lao CD, et al. Long-term outcomes of patients with active melanoma brain metastases treated with combination nivolumab plus ipilimumab (CheckMate 204): final results of an open-label, multicentre, phase 2 study. Lancet Oncol. 2021;22:1692\u2013704.","journal-title":"Lancet Oncol"},{"key":"2530_CR6","doi-asserted-by":"publisher","first-page":"e004509","DOI":"10.1136\/jitc-2022-004509","volume":"10","author":"C Franklin","year":"2022","unstructured":"Franklin C, Mohr P, Bluhm L, Grimmelmann I, Gutzmer R, Meier F, et al. Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. J Immunother Cancer. 2022;10:e004509.","journal-title":"J Immunother Cancer"},{"key":"2530_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11060-017-2695-2","volume":"137","author":"P Fang","year":"2018","unstructured":"Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, et al. Melanoma brain metastases harboring BRAF (V600K) or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol. 2018;137:67\u201375.","journal-title":"J Neurooncol"},{"key":"2530_CR8","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s11060-019-03171-6","volume":"143","author":"VK Kavouridis","year":"2019","unstructured":"Kavouridis VK, Harary M, Hulsbergen AFC, Lo YT, Reardon DA, Aizer AA, et al. Survival and prognostic factors in surgically treated brain metastases. J Neurooncol. 2019;143:359\u201367.","journal-title":"J Neurooncol"},{"key":"2530_CR9","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s11060-022-04036-1","volume":"158","author":"A Berger","year":"2022","unstructured":"Berger A, Bernstein K, Alzate JD, Mullen R, Silverman JS, Sulman EP, et al. Significant survival improvements for patients with melanoma brain metastases: can we reach cure in the current era? J Neurooncol. 2022;158:471\u201380.","journal-title":"J Neurooncol"},{"key":"2530_CR10","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/j.1755-148X.2012.01025.x","volume":"25","author":"CM Bailey","year":"2012","unstructured":"Bailey CM, Morrison JA, Kulesa PM. Melanoma revives an embryonic migration program to promote plasticity and invasion. Pigment Cell Melanoma Res. 2012;25:573\u201383.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2530_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10456-019-09695-9","volume":"23","author":"C Lugassy","year":"2020","unstructured":"Lugassy C, Kleinman HK, Vermeulen PB, Barnhill RL. Angiotropism, pericytic mimicry and extravascular migratory metastasis: an embryogenesis-derived program of tumor spread. Angiogenesis. 2020;23:27\u201341.","journal-title":"Angiogenesis"},{"key":"2530_CR12","doi-asserted-by":"publisher","first-page":"e5857","DOI":"10.1371\/journal.pone.0005857","volume":"4","author":"WS Carbonell","year":"2009","unstructured":"Carbonell WS, Ansorge O, Sibson N, Muschel R. The vascular basement membrane as \u201csoil\u201d in brain metastasis. PLoS One. 2009;4:e5857.","journal-title":"PLoS One"},{"key":"2530_CR13","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/cup.13465","volume":"46","author":"AK Rodewald","year":"2019","unstructured":"Rodewald AK, Rushing EJ, Kirschenbaum D, Mangana J, Mittmann C, Moch H, et al. Eight autopsy cases of melanoma brain metastases showing angiotropism and pericytic mimicry. Implications for extravascular migratory metastasis. J Cutan Pathol. 2019;46:570\u20138.","journal-title":"J Cutan Pathol"},{"key":"2530_CR14","doi-asserted-by":"publisher","first-page":"29254","DOI":"10.18632\/oncotarget.4201","volume":"6","author":"L Siam","year":"2015","unstructured":"Siam L, Bleckmann A, Chaung HN, Mohr A, Klemm F, Barrantes-Freer A, et al. The metastatic infiltration at the metastasis\/brain parenchyma-interface is very heterogeneous and has a significant impact on survival in a prospective study. Oncotarget. 2015;6:29254\u201367.","journal-title":"Oncotarget"},{"key":"2530_CR15","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1093\/neuonc\/not112","volume":"15","author":"AS Berghoff","year":"2013","unstructured":"Berghoff AS, Rajky O, Winkler F, Bartsch R, Furtner J, Hainfellner JA, et al. Invasion patterns in brain metastases of solid cancers. Neuro Oncol. 2013;15:1664\u201372.","journal-title":"Neuro Oncol"},{"key":"2530_CR16","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1046\/j.1523-1747.2002.01871.x","volume":"119","author":"R Barnhill","year":"2002","unstructured":"Barnhill R, Dy K, Lugassy C. Angiotropism in cutaneous melanoma: a prognostic factor strongly predicting risk for metastasis. J Invest Dermatol. 2002;119:705\u20136.","journal-title":"J Invest Dermatol"},{"key":"2530_CR17","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1365-2559.2012.04279.x","volume":"61","author":"J Wilmott","year":"2012","unstructured":"Wilmott J, Haydu L, Bagot M, Zhang Y, Jakrot V, McCarthy S, et al. Angiotropism is an independent predictor of microscopic satellites in primary cutaneous melanoma. Histopathology. 2012;61:889\u201398.","journal-title":"Histopathology"},{"key":"2530_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nm.2072","volume":"16","author":"Y Kienast","year":"2010","unstructured":"Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, Herms J, et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat Med. 2010;16:116\u201322.","journal-title":"Nat Med"},{"key":"2530_CR19","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/s41571-019-0181-9","volume":"16","author":"EA Kuczynski","year":"2019","unstructured":"Kuczynski EA, Vermeulen PB, Pezzella F, Kerbel RS, Reynolds AR. Vessel co-option in cancer. Nat Rev Clin Oncol. 2019;16:469\u201393.","journal-title":"Nat Rev Clin Oncol"},{"key":"2530_CR20","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41556-018-0138-8","volume":"20","author":"EE Er","year":"2018","unstructured":"Er EE, Valiente M, Ganesh K, Zou Y, Agrawal S, Hu J, et al. Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization. Nat Cell Biol. 2018;20:966\u201378.","journal-title":"Nat Cell Biol"},{"key":"2530_CR21","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1097\/CCO.0000000000000417","volume":"30","author":"G Seano","year":"2018","unstructured":"Seano G. Targeting the perivascular niche in brain tumors. Curr Opin Oncol. 2018;30:54\u201360.","journal-title":"Curr Opin Oncol"},{"key":"2530_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s10456-019-09684-y","volume":"23","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Wang S, Dudley AC. Models and molecular mechanisms of blood vessel co-option by cancer cells. Angiogenesis. 2020;23:17\u201325.","journal-title":"Angiogenesis"},{"key":"2530_CR23","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","volume":"156","author":"M Valiente","year":"2014","unstructured":"Valiente M, Obenauf AC, Jin X, Chen Q, Zhang XH, Lee DJ, et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell. 2014;156:1002\u201316.","journal-title":"Cell"},{"key":"2530_CR24","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang L, Zhang S, Yao J, Lowery FJ, Zhang Q, Huang WC, et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature. 2015;527:100\u20134.","journal-title":"Nature"},{"key":"2530_CR25","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/pcmr.12459","volume":"29","author":"T Zhang","year":"2016","unstructured":"Zhang T, Dutton-Regester K, Brown KM, Hayward NK. The genomic landscape of cutaneous melanoma. Pigment Cell Melanoma Res. 2016;29:266\u201383.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2530_CR26","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1056\/NEJMoa1502583","volume":"373","author":"AH Shain","year":"2015","unstructured":"Shain AH, Yeh I, Kovalyshyn I, Sriharan A, Talevich E, Gagnon A, et al. The Genetic Evolution of Melanoma from Precursor Lesions. N Engl J Med. 2015;373:1926\u201336.","journal-title":"N Engl J Med"},{"key":"2530_CR27","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/ng.356","volume":"41","author":"D Dankort","year":"2009","unstructured":"Dankort D, Curley DP, Cartlidge RA, Nelson B, Karnezis AN, Damsky WE Jr, et al. Braf(V600E) cooperates with Pten loss to induce metastatic melanoma. Nat Genet. 2009;41:544\u201352.","journal-title":"Nat Genet"},{"key":"2530_CR28","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.celrep.2015.09.057","volume":"13","author":"JH Cho","year":"2015","unstructured":"Cho JH, Robinson JP, Arave RA, Burnett WJ, Kircher DA, Chen G, et al. AKT1 activation promotes development of melanoma metastases. Cell Rep. 2015;13:898\u2013905.","journal-title":"Cell Rep"},{"key":"2530_CR29","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1158\/1078-0432.CCR-14-1027","volume":"20","author":"AD Bucheit","year":"2014","unstructured":"Bucheit AD, Chen G, Siroy A, Tetzlaff M, Broaddus R, Milton D, et al. Complete loss of PTEN protein expression correlates with shorter time to brain metastasis and survival in stage IIIB\/C melanoma patients with BRAFV600 mutations. Clin Cancer Res. 2014;20:5527\u201336.","journal-title":"Clin Cancer Res"},{"key":"2530_CR30","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/cam4.50","volume":"2","author":"H Niessner","year":"2013","unstructured":"Niessner H, Forschner A, Klumpp B, Honegger JB, Witte M, Bornemann A, et al. Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases. Cancer Med. 2013;2:76\u201385.","journal-title":"Cancer Med"},{"key":"2530_CR31","doi-asserted-by":"publisher","first-page":"7538","DOI":"10.1158\/1078-0432.CCR-09-1985","volume":"15","author":"MA Davies","year":"2009","unstructured":"Davies MA, Stemke-Hale K, Lin E, Tellez C, Deng W, Gopal YN, et al. Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin Cancer Res. 2009;15:7538\u201346.","journal-title":"Clin Cancer Res"},{"key":"2530_CR32","doi-asserted-by":"publisher","first-page":"eade8732","DOI":"10.1126\/scitranslmed.ade8732","volume":"15","author":"N Kanaya","year":"2023","unstructured":"Kanaya N, Kitamura Y, Lopez Vazquez M, Franco A, Chen KS, van Schaik TA, et al. Gene-edited and -engineered stem cell platform drives immunotherapy for brain metastatic melanomas. Sci Transl Med. 2023;15:eade8732.","journal-title":"Sci Transl Med"},{"key":"2530_CR33","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1111\/pcmr.12220","volume":"27","author":"MH Jenkins","year":"2014","unstructured":"Jenkins MH, Steinberg SM, Alexander MP, Fisher JL, Ernstoff MS, Turk MJ, et al. Multiple murine BRaf(V600E) melanoma cell lines with sensitivity to PLX4032. Pigment Cell Melanoma Res. 2014;27:495\u2013501.","journal-title":"Pigment Cell Melanoma Res"},{"key":"2530_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.ccr.2008.06.017","volume":"14","author":"AC Dudley","year":"2008","unstructured":"Dudley AC, Khan ZA, Shih SC, Kang SY, Zwaans BM, Bischoff J, et al. Calcification of multipotent prostate tumor endothelium. Cancer Cell. 2008;14:201\u201311.","journal-title":"Cancer Cell"},{"key":"2530_CR35","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11:783\u20134.","journal-title":"Nat Methods"},{"key":"2530_CR36","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1172\/JCI66236","volume":"123","author":"DA Knight","year":"2013","unstructured":"Knight DA, Ngiow SF, Li M, Parmenter T, Mok S, Cass A, et al. Host immunity contributes to the anti-melanoma activity of BRAF inhibitors. J Clin Invest. 2013;123:1371\u201381.","journal-title":"J Clin Invest"},{"key":"2530_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37807-z","volume":"14","author":"DJ Kim","year":"2023","unstructured":"Kim DJ, Anandh S, Null JL, Przanowski P, Bhatnagar S, Kumar P, et al. Priming a vascular-selective cytokine response permits CD8(+) T-cell entry into tumors. Nat Commun. 2023;14:2122.","journal-title":"Nat Commun"},{"key":"2530_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-52466-1","volume":"9","author":"JV McCann","year":"2019","unstructured":"McCann JV, Liu A, Musante L, Erdbrugger U, Lannigan J, Dudley AC. A miRNA signature in endothelial cell-derived extracellular vesicles in tumor-bearing mice. Sci Rep. 2019;9:16743.","journal-title":"Sci Rep"},{"key":"2530_CR39","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1172\/JCI123106","volume":"129","author":"JV McCann","year":"2019","unstructured":"McCann JV, Xiao L, Kim DJ, Khan OF, Kowalski PS, Anderson DG, et al. Endothelial miR-30c suppresses tumor growth via inhibition of TGF-beta-induced Serpine1. J Clin Invest. 2019;129:1654\u201370.","journal-title":"J Clin Invest"},{"key":"2530_CR40","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000320172","volume":"193","author":"S Lamouille","year":"2011","unstructured":"Lamouille S, Derynck R. Emergence of the phosphoinositide 3-kinase-Akt-mammalian target of rapamycin axis in transforming growth factor-beta-induced epithelial-mesenchymal transition. Cells Tissues Organs. 2011;193:8\u201322.","journal-title":"Cells Tissues Organs"},{"key":"2530_CR41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1083\/jcb.200611146","volume":"178","author":"S Lamouille","year":"2007","unstructured":"Lamouille S, Derynck R. Cell size and invasion in TGF-beta-induced epithelial to mesenchymal transition is regulated by activation of the mTOR pathway. J Cell Biol. 2007;178:437\u201351.","journal-title":"J Cell Biol"},{"key":"2530_CR42","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1074\/jbc.M306248200","volume":"279","author":"JC Horowitz","year":"2004","unstructured":"Horowitz JC, Lee DY, Waghray M, Keshamouni VG, Thomas PE, Zhang H, et al. Activation of the pro-survival phosphatidylinositol 3-kinase\/AKT pathway by transforming growth factor-beta1 in mesenchymal cells is mediated by p38 MAPK-dependent induction of an autocrine growth factor. J Biol Chem. 2004;279:1359\u201367.","journal-title":"J Biol Chem"},{"key":"2530_CR43","doi-asserted-by":"publisher","first-page":"10870","DOI":"10.1074\/jbc.M413223200","volume":"280","author":"JY Yi","year":"2005","unstructured":"Yi JY, Shin I, Arteaga CL. Type I transforming growth factor beta receptor binds to and activates phosphatidylinositol 3-kinase. J Biol Chem. 2005;280:10870\u20136.","journal-title":"J Biol Chem"},{"key":"2530_CR44","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-1-4939-7724-6_15","volume":"1755","author":"NY Bentolila","year":"2018","unstructured":"Bentolila NY, Barnhill RL, Lugassy C, Bentolila LA. Intravital imaging of human melanoma cells in the mouse ear skin by two-photon excitation microscopy. Methods Mol Biol. 2018;1755:223\u201332.","journal-title":"Methods Mol Biol"},{"key":"2530_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/srep23834","volume":"6","author":"LA Bentolila","year":"2016","unstructured":"Bentolila LA, Prakash R, Mihic-Probst D, Wadehra M, Kleinman HK, Carmichael TS, et al. Imaging of angiotropism\/vascular co-option in a murine model of brain melanoma: implications for melanoma progression along extravascular pathways. Sci Rep. 2016;6:23834.","journal-title":"Sci Rep"},{"key":"2530_CR46","doi-asserted-by":"crossref","unstructured":"Zhang Y, Riedstra CP, Wang S, Patel S, Bald T, Kumar P, et al. Melanoma cells appropriate pericyte:endothelial cell crosstalk during perivascular invasion in the brain. bioRxiv.2022.07.15.500231 [Preprint].","DOI":"10.1101\/2022.07.15.500231"},{"key":"2530_CR47","doi-asserted-by":"publisher","first-page":"742","DOI":"10.3390\/cancers12030742","volume":"12","author":"R Cabrita","year":"2020","unstructured":"Cabrita R, Mitra S, Sanna A, Ekedahl H, Lovgren K, Olsson H, et al. The role of PTEN loss in immune escape, melanoma prognosis and therapy response. Cancers (Basel). 2020;12:742.","journal-title":"Cancers (Basel)"},{"key":"2530_CR48","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1091\/mbc.E17-06-0406","volume":"29","author":"CC James","year":"2018","unstructured":"James CC, Zeitz MJ, Calhoun PJ, Lamouille S, Smyth JW. Altered translation initiation of Gja1 limits gap junction formation during epithelial-mesenchymal transition. Mol Biol Cell. 2018;29:797\u2013808.","journal-title":"Mol Biol Cell"},{"key":"2530_CR49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/neuonc\/noab159","volume":"24","author":"C Tehranian","year":"2022","unstructured":"Tehranian C, Fankhauser L, Harter PN, Ratcliffe CDH, Zeiner PS, Messmer JM, et al. The PI3K\/Akt\/mTOR pathway as a preventive target in melanoma brain metastasis. Neuro Oncol. 2022;24:213\u201325.","journal-title":"Neuro Oncol"},{"key":"2530_CR50","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1158\/1541-7786.MCR-13-0224-T","volume":"12","author":"JM Silva","year":"2014","unstructured":"Silva JM, Bulman C, McMahon M. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation. Mol Cancer Res. 2014;12:447\u201363.","journal-title":"Mol Cancer Res"},{"key":"2530_CR51","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.gendis.2022.12.015","volume":"10","author":"A Ertay","year":"2023","unstructured":"Ertay A, Ewing RM, Wang Y. Synthetic lethal approaches to target cancers with loss of PTEN function. Genes Dis. 2023;10:2511\u201327.","journal-title":"Genes Dis"},{"key":"2530_CR52","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1126\/science.280.5369.1614","volume":"280","author":"M Tamura","year":"1998","unstructured":"Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science. 1998;280:1614\u20137.","journal-title":"Science"},{"key":"2530_CR53","doi-asserted-by":"publisher","first-page":"ra18","DOI":"10.1126\/scisignal.2002138","volume":"5","author":"P Tibarewal","year":"2012","unstructured":"Tibarewal P, Zilidis G, Spinelli L, Schurch N, Maccario H, Gray A, et al. PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity. Sci Signal. 2012;5:ra18.","journal-title":"Sci Signal"},{"key":"2530_CR54","doi-asserted-by":"publisher","first-page":"e101402","DOI":"10.1371\/journal.pone.0101402","volume":"9","author":"EM Caspani","year":"2014","unstructured":"Caspani EM, Crossley PH, Redondo-Garcia C, Martinez S. Glioblastoma: a pathogenic crosstalk between tumor cells and pericytes. PLoS One. 2014;9:e101402.","journal-title":"PLoS One"},{"key":"2530_CR55","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/978-3-030-30651-9_7","volume":"1202","author":"A Kwiatkowska","year":"2020","unstructured":"Kwiatkowska A, Symons M. Signaling determinants of glioma cell invasion. Adv Exp Med Biol. 2020;1202:129\u201349.","journal-title":"Adv Exp Med Biol"},{"key":"2530_CR56","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1007\/s43440-023-00523-y","volume":"75","author":"K Brodaczewska","year":"2023","unstructured":"Brodaczewska K, Majewska A, Filipiak-Duliban A, Kieda C. Pten knockout affects drug resistance differently in melanoma and kidney cancer. Pharm Rep. 2023;75:1187\u201399.","journal-title":"Pharm Rep"},{"key":"2530_CR57","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s42003-021-02481-8","volume":"4","author":"M Rada","year":"2021","unstructured":"Rada M, Kapelanski-Lamoureux A, Petrillo S, Tabaries S, Siegel P, Reynolds AR, et al. Runt related transcription factor-1 plays a central role in vessel co-option of colorectal cancer liver metastases. Commun Biol. 2021;4:950.","journal-title":"Commun Biol"},{"key":"2530_CR58","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41413-022-00231-y","volume":"10","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zuo T, McVicar A, Yang HL, Li YP, Chen W. Runx1 is a key regulator of articular cartilage homeostasis by orchestrating YAP, TGFbeta, and Wnt signaling in articular cartilage formation and osteoarthritis. Bone Res. 2022;10:63.","journal-title":"Bone Res"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02530-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02530-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,22]],"date-time":"2024-02-22T21:24:52Z","timestamp":1708637092000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-023-02530-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,26]]},"references-count":58,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,3,9]]}},"alternative-id":["2530"],"URL":"https:\/\/doi.org\/10.1038\/s41416-023-02530-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,26]]},"assertion":[{"value":"18 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 November 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This project is considered non-human studies research and no IRB review was needed. All animal studies were performed in accordance with the University of Virginia guidelines for animal handling and care.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"All authors have been provided with a copy of the manuscript prior to submission and consent to publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}